|
US20020164350A1
(en)
|
1992-09-03 |
2002-11-07 |
Lowy Douglas R. |
Chimeric papillomavirus-like particles
|
|
US8062642B1
(en)
|
1993-03-09 |
2011-11-22 |
University Of Rochester |
Production of papillomavirus capsid protein and virus-like particles
|
|
EP1728800A1
(de)
*
|
1994-10-07 |
2006-12-06 |
Loyola University Of Chicago |
Papillomavirusähnliche Partikel, Fusionsproteine sowie Verfahren zu deren Herstellung
|
|
WO1998002548A2
(en)
*
|
1996-07-17 |
1998-01-22 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Infectious papillomavirus pseudoviral particles
|
|
DE19631357A1
(de)
*
|
1996-08-02 |
1998-02-05 |
Deutsches Krebsforsch |
Vektor zur Aktivierung des Immunsystems gegen mit Papillomviren bzw. Sequenzen davon assoziierten Zellen
|
|
GB9621091D0
(en)
|
1996-10-09 |
1996-11-27 |
Fondation Pour Le Perfectionem |
Attenuated microorganisms strains and their uses
|
|
ES2273376T3
(es)
*
|
1996-12-20 |
2007-05-01 |
MERCK & CO., INC. |
Formulaciones de vacunas recombinantes frente a papilomas.
|
|
AU755679B2
(en)
*
|
1997-07-03 |
2002-12-19 |
Medimmune, Llc |
Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture,and the use thereof as diagnostic, prophylactic or therapy
|
|
US7351533B2
(en)
*
|
1997-09-05 |
2008-04-01 |
Medimmune, Inc. |
In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
|
|
AU2003200653B2
(en)
*
|
1997-10-06 |
2007-01-18 |
Loyola University Of Chicago |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US6228368B1
(en)
*
|
1997-10-06 |
2001-05-08 |
Loyola University Of Chicago |
Papilloma virus capsomere formulations and method of use
|
|
US7182947B2
(en)
|
1998-02-20 |
2007-02-27 |
Medigene Ag |
Papillomavirus truncated L1 protein and fusion protein constructs
|
|
US20020039584A1
(en)
|
1998-02-20 |
2002-04-04 |
Medigene Ag |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US7494658B2
(en)
*
|
1998-02-20 |
2009-02-24 |
Medigene Ag |
Papilloma virus truncated L1 protein and fusion protein constructs
|
|
CA2229955C
(en)
|
1998-02-20 |
2003-12-09 |
Medigene Gmbh |
Papilloma virus capsomere vaccine formulations and methods of use
|
|
US6926897B1
(en)
*
|
1998-03-24 |
2005-08-09 |
Medigene Aktiengesellschaft |
Medicament for the avoidance or treatment of papillomavirus-specific tumour
|
|
DE19812940A1
(de)
*
|
1998-03-24 |
1999-10-07 |
Medigene Ag |
Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
|
|
GB9806666D0
(en)
*
|
1998-03-27 |
1998-05-27 |
Stanley Margaret |
Antigen preparation and use
|
|
DE69933875T2
(de)
*
|
1998-08-14 |
2007-05-31 |
Merck & Co., Inc. |
Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
|
|
US6991795B1
(en)
*
|
1998-08-14 |
2006-01-31 |
Merck & Co., Inc. |
Protein delivery system using human papillomavirus virus-like particles
|
|
ES2284287T3
(es)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
SE514982C2
(sv)
*
|
1999-09-30 |
2001-05-28 |
Active Biotech Ab |
Bärare innehållande ett huvudkapsidprotein L1 från humant papillomavirus samt dess användning
|
|
DE19925199A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
*
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
US20040146531A1
(en)
*
|
1999-09-30 |
2004-07-29 |
Active Biotech Ab |
Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells
|
|
US6908613B2
(en)
*
|
2000-06-21 |
2005-06-21 |
Medimmune, Inc. |
Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
|
|
ATE418997T1
(de)
*
|
2000-07-06 |
2009-01-15 |
Univ Georgetown |
Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
DE10137102A1
(de)
*
|
2001-07-30 |
2003-02-27 |
Deutsches Krebsforsch |
Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB0206360D0
(en)
*
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
US20060088909A1
(en)
*
|
2002-05-17 |
2006-04-27 |
Compans Richard W |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US9045727B2
(en)
*
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
US7407807B2
(en)
*
|
2002-05-17 |
2008-08-05 |
University Of Cape Town |
Chimaeric human papillomavirus 16 I1 virus like particles and a method for preparing the particles
|
|
US7858098B2
(en)
*
|
2002-12-20 |
2010-12-28 |
Glaxosmithkline Biologicals, S.A. |
Vaccine
|
|
US20080160040A1
(en)
*
|
2004-04-15 |
2008-07-03 |
Ghim Shin-Je |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
US7732166B2
(en)
*
|
2005-11-15 |
2010-06-08 |
Oncohealth Corporation |
Detection method for human pappilomavirus (HPV) and its application in cervical cancer
|
|
US7972776B2
(en)
*
|
2005-11-15 |
2011-07-05 |
Oncohealth Corporation |
Protein chips for HPV detection
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
US8778351B2
(en)
|
2006-08-30 |
2014-07-15 |
University Of Rochester |
Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors
|
|
CN101148661B
(zh)
*
|
2006-09-18 |
2013-01-02 |
中国医学科学院基础医学研究所 |
人乳头瘤病毒16型外壳蛋白病毒样颗粒及其制备方法和用途
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
US8968995B2
(en)
*
|
2008-11-12 |
2015-03-03 |
Oncohealth Corp. |
Detection, screening, and diagnosis of HPV-associated cancers
|
|
US8916342B2
(en)
|
2006-11-13 |
2014-12-23 |
Oncohealth Corp. |
Identification of high grade or ≧ CIN2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (HPV) and HPV-associated cancers
|
|
US20100003704A1
(en)
|
2008-06-13 |
2010-01-07 |
Shuling Cheng |
IN SITU detection of early stages and late stages HPV infection
|
|
WO2008115631A2
(en)
*
|
2007-02-08 |
2008-09-25 |
University Of Louisville Research Foundation, Inc. |
Plant-produced compositions for treating papillomavirus infection and related methods
|
|
CN103550764A
(zh)
|
2007-03-02 |
2014-02-05 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗组合物及其在刺激免疫反应中的用途
|
|
EP2154147B1
(en)
|
2007-04-29 |
2015-10-07 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
A truncated l1 protein of human papillomavirus 16
|
|
EP2147926B1
(en)
|
2007-04-29 |
2016-08-24 |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. |
Truncated human papillomavirus type 18 l1 proteins
|
|
EP2154149B1
(en)
*
|
2007-05-29 |
2019-07-10 |
Xiamen University |
A truncated l1 protein of human papillomavirus 6
|
|
US20100260792A1
(en)
*
|
2007-10-22 |
2010-10-14 |
University Of Rochester |
Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
|
|
WO2009076824A1
(zh)
*
|
2007-11-23 |
2009-06-25 |
Shanghai Zerun Biotechnology Co., Ltd. |
人乳头状瘤病毒主要衣壳蛋白l1基因及其用途
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
GB0820822D0
(en)
|
2008-11-13 |
2008-12-24 |
Inst Catala D Oncologia |
Novel product and processes
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
JP5819851B2
(ja)
|
2010-01-08 |
2015-11-24 |
オンコヘルス コーポレーション |
Ｈｐｖ関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力ｈｐｖ免疫アッセイ
|
|
NZ616304A
(en)
|
2011-04-08 |
2016-01-29 |
Immune Design Corp |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
EP2720716B1
(en)
*
|
2011-06-14 |
2018-03-21 |
Globeimmune, Inc. |
Immunotherapeutic compositions for the treatment or prevention of hepatitis delta virus infection
|
|
KR102049988B1
(ko)
|
2011-06-24 |
2019-11-28 |
머크 샤프 앤드 돔 코포레이션 |
알루미늄 아주반트를 포함하는 hpv 백신 제제 및 그의 제조 방법
|
|
JP6198278B2
(ja)
|
2011-09-08 |
2017-09-20 |
ユニキュアー アイピー ビー．ブイ． |
Ａａｖ調製物からの混入ウイルスの除去
|
|
PL2811981T3
(pl)
|
2012-02-07 |
2019-09-30 |
Infectious Disease Research Institute |
Ulepszone formulacje adiuwantowe zawierające agonistę TLR4 oraz sposoby ich zastosowania
|
|
CN104203270A
(zh)
|
2012-03-18 |
2014-12-10 |
葛兰素史密丝克莱恩生物有限公司 |
针对人乳头状瘤病毒的接种方法
|
|
SMT201800368T1
(it)
|
2012-05-16 |
2018-09-13 |
Immune Design Corp |
Vaccini per l'infezione da virus-2 herpes simplex
|
|
CA2909221A1
(en)
|
2013-04-18 |
2014-10-23 |
Immune Design Corp. |
Gla monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
CN104231060B
(zh)
*
|
2013-06-05 |
2018-05-15 |
厦门大学 |
人乳头瘤病毒l1l2衣壳蛋白相互作用位点及其应用
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
KR102483033B1
(ko)
|
2016-05-16 |
2022-12-30 |
액세스 투 어드밴스드 헬스 인스티튜트 |
페길화된 리포솜 및 이의 용도
|
|
RU2761870C2
(ru)
|
2016-05-16 |
2021-12-13 |
Инфекшес Дизис Рисёрч Инститьют |
Состав, содержащий агонист tlr, и способы применения
|
|
EP3463300A1
(en)
|
2016-06-01 |
2019-04-10 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
|
AU2018285694B2
(en)
|
2017-06-15 |
2025-04-10 |
Access To Advanced Health Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
|
EP3678695A1
(en)
|
2017-09-08 |
2020-07-15 |
Infectious Disease Research Institute |
Liposomal formulations comprising saponin and methods of use
|
|
WO2020139843A1
(en)
*
|
2018-12-28 |
2020-07-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Engineered hepatitis b core polypeptide
|
|
BR112021023726A2
(pt)
|
2019-05-25 |
2022-02-15 |
Infectious Disease Res Inst |
Composição e método para secagem por pulverização de uma emulsão de vacina adjuvante
|
|
WO2021013071A1
(zh)
|
2019-07-19 |
2021-01-28 |
神州细胞工程有限公司 |
人乳头瘤病毒多价免疫原性组合物
|
|
WO2021013067A1
(zh)
*
|
2019-07-19 |
2021-01-28 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒6型l1蛋白
|
|
WO2021013079A1
(zh)
*
|
2019-07-19 |
2021-01-28 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒56型l1蛋白
|
|
CN114127295B
(zh)
*
|
2019-07-19 |
2024-05-14 |
神州细胞工程有限公司 |
嵌合的人乳头瘤病毒16型l1蛋白
|
|
HUE073111T2
(hu)
|
2019-07-19 |
2026-01-28 |
Sinocelltech Ltd |
Kiméra papillomavírus L1 fehérje
|
|
US12673103B2
(en)
|
2020-02-14 |
2026-07-07 |
Merck Sharp & Dohme Llc |
HPV vaccine
|
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
CN114539363B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种c端改造的人乳头瘤病毒11型l1蛋白及其用途
|
|
CN114539365B
(zh)
*
|
2020-11-26 |
2023-12-01 |
中国医学科学院基础医学研究所 |
一种改造的人乳头瘤病毒52型l1蛋白及其用途
|
|
MX2023009456A
(es)
|
2021-02-11 |
2023-08-28 |
Glaxosmithkline Biologicals Sa |
Preparacion de la vacuna contra el vph.
|
|
WO2022268811A1
(en)
|
2021-06-21 |
2022-12-29 |
Uniqure Biopharma B.V. |
Improved lysis procedures
|
|
WO2023014853A1
(en)
|
2021-08-06 |
2023-02-09 |
Merck Sharp & Dohme Llc |
Hpv vaccine
|
|
AR126813A1
(es)
|
2021-08-19 |
2023-11-15 |
Merck Sharp & Dohme Llc |
Nueva nanopartícula lipídica termostable y métodos de uso de la misma
|
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|
|
CR20250529A
(es)
|
2023-06-09 |
2026-01-12 |
Merck Sharp & Dohme Llc |
Composiciones adyuvantes en nanoemulsión para vacunas contra el papilomavirus humano
|